Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity - NIPPON DATA90, 1990-2000

被引:104
作者
Kadota, Aya
Hozawa, Atsushi
Okamura, Tomonori
Kadowak, Takashi
Nakmaura, Koshi
Murakami, Yoshitaka
Hayakawa, Takehito
Kita, Yoshikuni
Okayama, Akira
Nakamura, Yasuyuki
Kashiwagi, Atsunori
Ueshima, Hirotsugu
机构
[1] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Dept Internal Med, Otsu, Shiga 5202192, Japan
[3] Shimane Univ, Dept Publ Hlth Sci, Izumo, Shimane, Japan
[4] Natl Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka 565, Japan
[5] Kyoto Womens Univ, Kyoto, Japan
关键词
D O I
10.2337/dc06-2074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Metabolic syndrome is diagnosed according to several criteria. Of these, some require glucose intolerance and others require obesity for the diagnosis. We investigated the relationship between metabolic risk factor clustering and cardiovascular disease (CVD) mortality stratified by high blood glucose or obesity. RESEARCH DESIGN AND METHODS - We followed 7,219 Japanese men and women without a history of CVD for 9.6 years. We defined high blood pressure, high blood glucose, high triglycerides. low HDL cholesterol, and obesity as metabolic factors. The multivariate adjusted hazard ratio (HR) for CVD mortality according to the number of clustering metabolic factors was calculated using the Cox proportional hazards model. RESULTS - During follow-up, 173 participants died of CVD. The numbers of metabolic risk factors and CVD mortality were positively correlated (P-trend = 0.07). The HR was obviously higher among participants With than among those without high blood glucose and clustering of >= 2 other metabolic risk factors (HR 3.67 [95% CI 1.49-9.03]). However, the risk increase was only modest in participants without high blood glucose even if they had; >= 2 other metabolic risk factors (1.99 [0.93-4.28]). Conversely, metabolic risk factor clustering was related to CVD mortality irrespective of obesity. CONCLUSIONS - Our findings suggest that glucose tolerance plays an important role in CVD mortality. Because the prevalence of nonobese participants with several metabolic risk factors was quite high and their CVD risk was high, excluding them from the diagnosis of metabolic syndrome because of the absence of obesity might overlook their risk.
引用
收藏
页码:1533 / 1538
页数:6
相关论文
共 31 条
  • [1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [2] Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
  • [3] 2-S
  • [4] Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] Body mass index and mortality from cardiovascular disease among Japanese men and women - The JACC study
    Cui, RZ
    Iso, H
    Toyoshima, H
    Date, C
    Yamamoto, A
    Kikuchi, S
    Kondo, T
    Watanabe, Y
    Koizumi, A
    Wada, Y
    Inaba, Y
    Tamakoshi, A
    [J]. STROKE, 2005, 36 (07) : 1377 - 1382
  • [7] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194
  • [8] Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence
    Ford, ES
    [J]. DIABETES CARE, 2005, 28 (07) : 1769 - 1778
  • [9] CONTRIBUTION OF INTRAABDOMINAL FAT ACCUMULATION TO THE IMPAIRMENT OF GLUCOSE AND LIPID-METABOLISM IN HUMAN OBESITY
    FUJIOKA, S
    MATSUZAWA, Y
    TOKUNAGA, K
    TARUI, S
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (01): : 54 - 59
  • [10] Gavin JR, 1997, DIABETES CARE, V20, P1183